TABLE 5.

Summary of mycological and clinical efficacies of different medicated water-soluble films.

	Clinical efficacy			Mycological efficacy
Water-soluble films	% efficacy	Mean clinical score ± SD	p-value compared to untreated group	% efficacy	Mean clinical score ± SD	p-value compared to untreated group
M/U 40 film	95.83	0.2 ± 0.44a	0.001	95.83	0.2 ± 0.44b	<0.001
M/U 20 film	95.83	0.2 ± 0.44c	<0.001	95.83	0.2 ± 0.44d	<0.001
M/U 10 film	37.5	3 ± 0.71	0.06	33.3	3.2 ± 0.84	0.06
M	29.16	3.4 ± 0.45	0.08	25	3.6 ± 1.4	0.13
U40	8.35	4.4 ± 0.44	0.6	12.5	4.2 ± 0.83	0.51
U20	8.35	4.4 ± 0.44	0.3	4.16	4.6 ± 0.54	0.8
U10	0	4.8 ± 0.45	0.9	0	4.8 ± 0.45	0.35
Placebo films	0	4.8 ± 0.45	0.17	0	4.8 ± 0.45	0.64
Infected untreated group	–	4.8 ± 0.44	NAe	–	5 ± 0.0	NA

^a,b,c,d(p-value 0.001) to treatment and placebo film, ^eNA not applicable.